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Ankylosing Spondylitis and related spondyloarthropathies form a 
family of rheumatic diseases that are characterized by inflammatory 
peripheral and axial arthritis, with predilection for sacroiliitis, and a 
remarkably strong association with a genetic marker, HLA-B27. The 
association with B27 has provided a great impetus to the epidemio-
logic studies of spondyloarthropathies and also helped broaden the 
clinical spectrum of these diseases. There are at least six Subtypes of 
B27, and the x-ray crystallographic structure of the common B27 
subtype (B*2705) is now known. Endogenous peptides bound in the 
B27 antigen-binding cleft have been isolated and all seem to be 
nonamers (i.e., nine amino acids long). 
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The close association of HLA-B27 with arthritic conditions has led to 
the Suggestion that these diseases are mediated by cytotoxic T lym-
phocytes that recognize self-peptides presented by HLA-B27 mole-
cules. The further association with enteric bacterial infections sug-
gests that bacterial antigens may prime the CTL that later crossreacts 
on seif. Bacterial infections do not usually generate CTL responses. 
We speculate here that unusual properties of HLA-B27 molecules 
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may predispose to such responses. Thus, HLA-B27-related disease 
may be an unfortunate consequence of the generation of a suitable, 
self-mimicking HLA-B27-binding peptide by certain bacteria, plus 
an unusual propensity for the HLA-B27 molecule to bind and 
present such peptides. 
Gut and Spondyloarthropathies 
Marjatta Leirisalo-Repo and Heikki Repo 
In recent studies, ileocolonoscopy has revealed ileal or colonic in-
flammatory changes in 30% to 60% of patients with spondyloar-
thropathies. In patients with a short duration of arthritis, the 
changes are similar to those observed in patients with bacterial en-
teritis. In those with prolonged or chronic spondyloarthropathy, the 
changes show chronic inflammation, with features of Crohn's dis-
ease in a quarter of the patients. It is tempting to speculate that 
infection leads to chronic gut inflammation with increased absorp-
tion of bacterial products that may contribute to the development of 
arthritis and Spondylitis. The microbes probably do not persist in the 
host in a dividing form, because contrary to patients with chla-
mydia-triggered reactive arthritis, the prolonged use of antimicrobial 
chemotherapy in patients with acute enteroarthritis does not influ-
ence the natural course of the arthritis. The use of sulf asalazine in the 
rreatment of spondyloarthropathies seems to be promising. 
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Acute enteric infections caused by Yersiniae, Salmonellae, Shigellae, 
and Campylobacters are sometimes, especially in HLA-B27-
positive persons, followed by development of reactive arthritis. The 
role of bacterial antigens in the pathogenesis of this complication is 
discussed in this article. Several differences in immune responses 
against causative agents between patients developing or not develop-
ing reactive arthritis after these infections are described. It is obvious 
that microbial antigens are not properly eliminated, and they persist 
for long times in HLA-B27 persons developing reactive arthritis. 
They are also found to exist in joints where they probably have an 
important role in starting inflammation. 
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Gabrielle Kingsley and Gabriel Panayi 
In reactive arthritis, there is a synovial immune response specific for 
the triggering bacterial antigen. The response is mediated by syn-
ovial T cells in response to fragments of antigen found in the Joint, 
and the humoral immune response plays only a secondary role. 
Detailed analysis is important not only to understand disease patho-
genesis but also for diagnosis and development of new therapies. 
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otic therapy of RS. 
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report the results of the epidemiologic work and of the study of the 
effects of antibiotic treatment of venereal inf ection. In Reiter's Syn-
drome patients, treatment of venereal infections by erythromycin or 
tetracycline was associated with a significant reduction in the rate of 
postvenereal arthritic flares. 
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The suggested relationship of Klebsiella species to the pathogenesis 
of ankylosing Spondylitis reflects evidence that there was an increase 
in f ecal Klebsiella carriage in patients with active AS when compared 
to controls, that B27-positive lymphocytes from AS patients could be 
distinguished from normal B27-positive lymphocytes by an anti-
serum, and that a nitrogenase enzyme found in some species of 
Klebsiella had a sequence of six amino acids identical to a sequence 
seen in B*2705. It is the authors' view that the superficial sinülarities 
between these observations has been the chief factor leading to their 
support but that on close Observation none are attractive either on 
pragmatic or on intuitive grounds. 
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Ankylosing Spondylitis is a form of reactive arthritis following Kleb-
siella inf ection, usually occurring in an HLA-B2 7-positive individ-
ual. This conclusion is based on evidence obtained from several 
diseiplines: immunogenetic studies show that there is molecular 
mimicry between HLA-B27 and Klebsiella; increased isolation of 
fecal Klebsiella has been reported in both Europe and North Amer-
ica; and finally, antibodies to Klebsiella have been demonstrated in 
ankylosing Spondylitis patients in England and Finland. It is sug-
gested that therapeutic trials should be set up with the aim of elimi-
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nating Klebsiella microbes, in an endeavor to test the validity of this 
theory. 
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Juvenile ankylosing Spondylitis (JAS) is a term that means ankylos-
ing Spondylitis starting before the age of 16. JAS is a disease in which 
individuals younger than 16 years of age have inflammation of the 
vertebral joints leading to stiffening of the spine. JAS is a clinical 
diagnosis based on retrospective data, because most patients de-
velop ankylosis of the vertebrae many years after the appearance of 
arthritis, enthesitis, or other Symptoms of the disease. 
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An acute onset, unilateral anterior Uveitis occurs during the course of 
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many patients who suffer from an acute anterior Uveitis are H L A -
B27-positive and have associated Joint disease. The consistent pre-
sentation of the Uveitis can aid in the process of differential diagno-
sis. This article includes a discussion of the recognition of the 
characteristic presentation, the complications, the role of B27 testing, 
the relevance of animal models, the pathogenesis, and treatment. 
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Ankylosing Spondylitis (AS) has a striking disease marker, i.e., H L A -
B27, indicating the major genetic predisposition; however, expres-
sion of disease is also strongly influenced by age- and sex-related 
factors. Sex Steroids studies suggest greater androgenicity in AS than 
normal control persons. Therapeutic interventions that normalize 
such sex Steroid Status have shown clinical improvements in males 
and females. Muscle histopathology in AS shows frequent changes 
early in disease consistent with neuropathic and myopathic mecha-
nisms of a noninflammatory nature. Accepting the available, aggre-
gate data, one may inf er that sex Steroid imbalance in persons suscep-
tible to AS may target axial and proximal muscle tissues, resulting in 
relative functional hypertonicity. Such phenomenon, developing in 
preteen and younger adult ages, may contribute to peripheral and 
axial manifestations of enthesopathy in this disease by complex and 
currently unknown mechanisms. 
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polyenthesitis may have an infectious origin. 
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The strongest association of a HLA allele with rheumatic diseases has been 
found between HLA-B27 and ankylosing Spondylitis (AS). 5 3 Among Caucasian 
people, the prevalence of HLA-B27 in the general population is about 8%, whereas 
this antigen is found in more than 90% in patients with AS. The association shows a 
dominant or additive mode of inheritance. Among B27-positive individuals less 
than 2% will develop AS, although the prevalence of AS in adult B27-positive 
first-degree relatives of B27-positive AS patients is at least tenfold higher.5 7-5 8 This 
increase among relatives in affected families prompted the hypothesis that other 
genetic factors might participate additively with the B27 allele in the susceptibility 
to AS. 
The distribution of non-B27 alleles of the HLA-B locus among B27-positive 
patients with AS has been studied to detect any additional HLA-B allele(s) that may 
act in conjunction with B27 to increase susceptibility to AS. HLA-Bw60 (or B40 
when the Bw60,61-split of B40 was not typed for) was statistically shown to be 
increased significantly among B27-positive AS patients in each of five independent 
data sets. Susceptibility to AS in B27-positive individuals was further increased by a 
factor of about three when Bw60 was also present.44 
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Two major theories have been proposed to explain the association between B27 
and AS. 3 The one gene theory suggests that the HLA-B27 antigen itself is directly 
involved in the pathogenesis of the disease, either through its function as restriction 
element for T lymphocytes or through another yet unknown function of the B27 
molecule. 1 6 5 1 / 6 2 With regard to this theory, the additional genetic factors could be 
either HLA-linked or segregate independently of the H L A complex. The two gene 
theory postulates that the B27 molecule itself is not involved but is a marker for a 
second HLA-linked gene in strong linkage disequilibrium with HLA-B27 that causes 
or permits the development of the disease.31 
GENETIC ORGANIZATION OF THE HLA SYSTEM 
The human major histocompatibility complex (MHC), located on the short arm 
of chromosome 6, comprises a chromosomal segment of 3500 kb (Fig. 1 ). 2 6 A molecu-
lar linkage map of the H L A complex has been established by linkage analysis and 
recently by pulsed-field gel electrophoresis. 8 4 2' 1 3' 4 2 It contains a large number of loci 
that, based on structure and function of the encoded proteins, have been organized 
into three gene Clusters. Located at the telomeric end of the HLA complex is the class 
I region encoding the classical transplantation antigens H L A - A , -C, and -B. At the 
centromeric end, the class II genes are located, consisting of HLA-DP, -DO, -DV, 
-DQ, and -DR. The class I and class II molecules are cell-surface glycoproteins 
regulating antigen recognition by T lymphocytes. Between the class I and class II 
region is the class III region, originally characterized as a heterogeneous group of 
genes encoding complement factors (C2, Bf, C4A, and C4B).6 Several genes for 
previously known proteins have been localized in the class III region: Steroid 21-
hydroxylase (21 O H A and 210HB), 7 the tumor necrosis factor (TNF) genes TNF-a 
(cachectin), and TNF-/? (lymphotoxin), 8 ' 1 3 ' 2 0 ' 3 6- 4 2 and the heat shock proteins (HSP 
70), two highly homologous copies and one more divergent gene. 3 3 4 7 In addition, a 
large number of sequences have been described, characterized by unmethylated 
CpG-rich sequences that are constitutively transcribed; either called, owing to their 
location in between C2 and HLA-B, B-associated transcripts (BAT 1-9)48-49 or G-loci 
(G 1-10).46 Moreover, eight additional genes (G 11-18) have been identified by the 
same approach centromeric of C2 . 2 5 In analogy to the M H C of the mouse, a human 
sequence homologous to the murine B144 gene55 has been characterized 5' of the 
human TFN-a gene (Holzinger I et al, unpublished data). 
Because of the localization and the biologic activities of the genes encoding 
HSP70 and TNF, it has been suggested that these loci might contribute to the 
susceptibility of HLA-associated diseases. 8 2 7 , 4 7 
The HSP70 proteins, induced in response to cellular stress, belong to the family 
of so called stress proteins (HSP60, HSP70, and HSP90) that are evolutionary 
conserved between prokaryotes and eukaryotes. Stress proteins play a cell protec-
tive role and are involved in post-translational protein assembly and protein trans-
location.2 4 
Figure 1. Genetic map of the HLA complex with the genes encoded by the class I, II, and III 
regions. The middle line shows an extension of the class II region of 900 kb between HLA-DR 
and HLA-B. The bottom graph displays the Organization of the TNF-a and -ß genes, with the 
introns (open bars) and exons (closed bars). The Nco I and EcoR I restriction Sites are shown, 
and the Polymorphie restriction sites are indicated (asterisks). The arrows signify the transcrip-
tional orientation. (Data from references 12, 25, 34, 37, 43, 47 and 50.) 
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The TNF genes encode closely related cytokines with a broad ränge of biologic 
activities and are primary produced by macrophages and activated lymphocytes.4 
Biologic effects of TNF include the regulation of the immune response by the induc-
tion of gene expression, such as HLA antigens, 1 0 4 1 activation of polymorphonuclear 
leukocytes, and cytotoxic effects against tumor cells. 2 8 , 3 9 
RESTRICTION FRAGMENT LENGTH POLYMORPHISM 
ANALYSIS IN ANKYLOSING SPONDYLITIS 
Genetic polymorphism is essential for the biologic function of proteins such as 
class I and class II M H C antigens. Recombinant D N A technology facilitates and 
increases the identification of genetic polymorphisms. In addition, the use of restric-
tion fragment length polymorphisms (RFLPs), by hybridization of restriction en-
zyme digested genomic D N A with radio-labeled cloned D N A probes, provides a 
powerful tool for the diagnosis of hitherto undetectable disease states and enables 
the chromosomal localization of the loci responsible. 
Düring the past years, several groups have employed RFLP analysis, using class 
I MHC cDNA or genomic probes, to identify additional genes besides HLA-B27 
involved in the pathogenesis of AS. No RFLP linked with AS has been identified so 
far.6 1 A 9.6 kb Pvu II fragment37 and a 3.5 kb Taq I fragment54 were equally present 
in B27-positive AS patients as in B27-positive controls. A 9.2 kb Pvu II fragment was 
reported by one group to be increased significantly in B27-positive AS patients 
compared to B27-positive controls30; however, this could not be conflrmed by two 
other studies.1 5 , 6 1 
In addition, it has been postulated that Polymorphie T-cell reeeptor (TcR) a 
and /or ß genes might conf er susceptibility to AS. A preliminary RFLP analysis of the 
TcR a and ß genes in patients with AS showed no disease association with the TcR 
alleles studied.14 
GENETIC POLYMORPHISM OF THE TUMOR NECROSIS 
FACTOR REGION 
In mouse model Systems, autoimmunity has been attributed to a low TNF-a 
response in NOD-mice with diabetes21 and mice prone for lupus nephritis 
(NZWxNZB, F l ) . 2 3 Application of TNF could prevent the autoimmune phenomena. 
A RFLP has been described for the TNF-a gene in the mouse. No studies, however, 
have been analyzed so far as to whether one of the TNF-a alleles might correlate 
with a low TNF-a response.43 
The localization of the human TNF genes, analogue to the murine TNF 
genes,34-35 in the HLA complex initiated investigations to detect polymorphisms in 
the human TNF genes. Two of 40 endonucleases tested, Eco RI and Nco I, revealed a 
Polymorphie pattern when hybridized with TNF cDNA probes. 1 7 , 3 8 The Polymor-
phie Eco RI site maps to the 3' untranslated region of TNF-/? gene (exon 4) (Fig. 1) 
resulting in either a 2.4 kb or a 2.5 kb Eco RI fragment.38 The polymorphic Nco I 
recognition sequence has been detected by Nedospasov et a l 3 6 by comparison of the 
cloned genomic TNF-/? sequences when the M H C localization of the TNF genes 
was not known. The polymorphic Nco I site was later wrongly assigned to the 
TNF-a gene. 2 , 1 1 1 7 , 1 8 The location within the first intron of the TNF-/? gene was 
finally conflrmed by genomic Southern blot analysis using both a TNF-a and 
a TNF-/? probe, by restriction site mapping of cloned genes, and by direct genomic 
sequencing.1-32'59'60 
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In Nco I-digested genomic DNA, the TNF-a probe hybridizes with either a 
fragment of 5.5 kb (indicate for the TNF/?*1 allele) or a 10.5 kb fragment (encoding 
the TNF/?*2 allele), whereas the TNF-/? probe detects both a 5.5 kb and a 5 kb Nco I 
fragment or the 10.5 kb fragment (Fig. 1). The Eco RI and the Nco I RFLP of the 
TNF-/? gene segregate independently, enabling four TNF-/? alleles to be analyzed by 
RFLP typing. 3 2 
It has been shown recently that the polymorphic Nco I restriction site is linked 
to an amino acid Substitution in the native TNF-/? protein.3 2 The arrüno-terminal 
asparagine at position 26 is conserved in the TNF/?*1 allele and threonine in the 
TNF/?*2 allele. The significance of this Single amino acid Substitution with regard to 
the biologic activities of TNF-/? is not known. 
THE Nco I TNF-)? RFLP IN RELATION TO 
CYTOKINE PRODUCTION 
The molecular analysis of the TNF-/? RFLPs led to the question whether these 
polymorphisms might be involved in differential cytokine secretion. A recent study 
analyzed the secretion of interleukin 1 beta (IL-1 /?) and TNF-a of monocytes, 
stimulated with lipopolysaccharide and phytohemagglutinin.40 Homozygosity for 
TNF/?*2 correlated with high secretion levels of both IL-1 ß and TNF-a, whereas 
heterozygosity was associated with low secretion levels of IL-1 ß and TNF-a . In 
contrast, no association of the TNF-a production on lipopolysaccharide or mitogen 
Stimulation of monocytes or peripheral blood mononuclear cells with the Nco I 
RFLP has been observed by Jacob et a l . 2 2 In an analysis of the TNF-a and TNF-/? 
production by phytohemagglutinin-stimulated peripheral blood mononuclear cells 
in individuals homozygous for the Nco I TNF-/? alleles, no significant differences in 
TNF-a secretion was detected, whereas donors homozygous for the TNF/?*1 allele 
showed a signifkantly higher TNF-/? production compared to individuals homozy-
gous for the TNF/?*2 allele.3 2 Furthermore, Sachs et a l 4 5 reported a signifkantly 
reduced TNF-/? response in insulin-dependent diabetes mellitus (IDDM) patients. 
The genetic basis responsible for the differences in the production of TNF-a is not 
known so far. In conclusion, these data show that the Nco I TNF-/? alleles are 
associated with distinct cytokine secretion profiles. 3 2' 4 0 
TNF-/? RFLP ANALYSIS IN VARIOUS DISEASES 
In humans, the Eco RI RFLP of the TNF-/? gene is low informative: the less 
common fragment (2.5 kb) is present at a low frequency (6%) in the Caucasian 
population. 3 8- 5 9 Moreover, the 2.5 kb fragment is strongly associated with HLA-
Bw60. 5 9 
The frequencies of the Nco I fragments are 67% to 71% and 29% to 33%, 
respectively.17-32 The TNF/?*2 allele is associated with HLA-DR4 and -B15, whereas 
the TNF/?*1 is strongly associated with the H L A - A l , -B8, -DR3 haplotype.2-11-40 
Because the AI/B8/DR3 haplotype is known to be strongly associated with various 
immunoinflammatory diseases, it has been suggested that a particular TNF-/? allele 
might be involved in the pathogenesis of these diseases.11-50 
Fugger et a l 1 7 - 1 8 have analyzed the frequency of the Nco I TNF-/? RFLP in small 
groups of patients with various diseases, including primary biliary cirrhosis (PBC), 
pauciarticular juvenile rheumatoid arthritis (P-JRA), rheumatoid arthritis (RA), pri-
mary Sjögren's S y n d r o m e (pSS), and systemic lupus erythematosus (SLE) (Table 1). 
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Table 1. TUMOR NECROSIS FACTOR REGION Nco I R F L P 
P H E N O T Y P E S IN PATIENTS AND C O N T R O L S U B J E C T S * 
Nco I Fragment 
5.5 kb+, 5.5 kb+, 5.5 kb-, 
Study Group 10.5 kb- 10.5 kb+ 10.5 kb+ N 
Patients 
P B C 1 7 6 (27.3) 9 (40.9) 7(31.8) 22 
pBQ32a 6(10) 24 (40) 30 (50) 60 
RA 1 8 3(12.5) 6(25) 15(62.5) 24 
RAf 4(11) 19(52.8) 13(36.1) 36 
S L E 1 8 6(30) 7(35) 7(35) 20 
P-JRA 1 8 9(18.4) 24 (49) 16(32.7) 49 
pSS 1 8 2(10.5) 14(73.7) 3(15.8) 19 
Controls 
Random controls18 8(6.1) 60 (45.8) 63(48.1) 131 
Random controls328 20 (11.2) 78 (43.6) 81 (45.2) 179 
Patients40 
Random IDDM 3(11.1) 17(63) 7 (25.9) 27 
DR3+, DR4+, DQw8+ IDDM 3(11.5) 17(65.4) 6(23.1) 26 
Controls40 
Random controls 3(12) 9(36) 13(52) 25 
DR34-, DR4+, DQw8+ controls 4 (30.8) 8(61.5) 1 (7.7) 13 
* Values are the number (%), RFLP = restriction fragment length polymorphism. 
t Messer G et al, personal communication. 
Data from references 17,18, 32, 32a, and 40. 
The TNF/?*2 allele was decreased signifkantly in primary biliary cirrhosis and sys-
temic lupus erythematosus patients. In the latter group, this is probably secondary to 
the strong association between HLA-B8 and the TNF/?*1 allele.11 Moreover, in a 
larger group of primary biliary cirrhosis patients analyzed by Messer et a l , 3 2 a no 
deviation in the frequency of the Nco I TNF-/? alleles was observed. 
Susceptibility to IDDM is associated with HLA-DR3 or -DR4 or both, with 
heterozygosity for both alleles conferring the highest risk.50-53 It has been postulated 
that loci within the class III M H C region contribute to IDDM. 5 - 5 2 Two groups have 
studied the TNF-/?RFLP in IDDM patients.2 4 0 Badenhoop et al 2 analyzed 43 infor-
mative diabetic families (79 IDDM patients), but owing to the small number of 
HLA-matched controls, the gene frequencies in patients could only be compared 
with a randomly selected control group. In patients, the DR4 specificity was strongly 
associated with the TNF£*2 allele (77%), and 30% of DR3 haplotypes also carried 
the TNF/?*2 allele. Similar results have been obtained by Pociot et a l 4 0 studying DR3, 
4 heterozygous IDDM patients (N = 26) in comparison to DR-matched healthy 
controls (N = 19). In HLA-DR3, 4 individuals, the DR3 haplotypes carried the 
TNF/?*2 allele three times more frequently in IDDM patients than in controls. It was 
suggested that the TNF/?*2 allele, when present on the DR3-haplotype, may contrib-
ute to susceptibility to IDDM in HLA-DR3, 4 heterozygous individuals.4 0 In addi-
tion, sibpair analysis in multiplex families showed that sibpairs concordant for 
IDDM were identical for the TNF-/? alleles,40 even if they were only haploidentical 
for HLA-B-DR haplotypes.2 
In addition, the frequency of the Nco I RFLP has also been analyzed in patients 
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with multiple sclerosis and optic neuritis. No association with a TNF-/? allele was 
found. 1 9 
TNF-/? RFLP ANALYSIS IN PATIENTS WITH 
ANKYLOSING SPONDYLITIS 
Recently, we tested whether a polymorphism of the TNF-/? gene confers an 
additional risk of AS in B27-positive individuals.5 9 Because the Nco I TNF-)? RFLP 
frequency was not signifkantly different between patients with AS and controls, it 
was concluded that neither Nco I TNF-/? alleles are associated with A S . 5 9 
In view of the suggested synergistic effect of B27 and Bw60 in A S , 4 4 we investi-
gated the possible association between Bw60 and the Nco I and EcoR I RFLP, 
respectively, of the TNF-/? gene. Although a significant association was found be-
tween Bw60 and the EcoR I 2.5 kb fragment, RFLP analysis with Eco RI of B27, 
Bw60 heterozygous AS patients and control subjects suggests that the increased risk 
for AS in this group of individuals is probably not due to the presence of the 
particular TNF-/? allele characterized by the 2.5 kb EcoR I fragment.59 Because this 
study was limited to RFLP analysis in unrelated individuals only, it does not exclude 
the possibility that TNF polymorphisms or differences only detectable by allelic 
sequencing are involved in AS susceptibility. 
Although the search for additional genes in the HLA complex, contributing to 
the disease susceptibility of HLA-B27, was unsuccessful so far and current knowl-
edge favors that B27 itself is directly involved, substantial evidence remains that 
other genetic factors besides HLA-B27 are involved in the pathogenesis of AS. 3 - 4 4 At 
this moment, there is no direct evidence that these alleles are carried by the B27 
haplotype,29 but are more likely located on the non-B27 haplotype (possibly the 
Bw60 haplotype) or elsewhere in the genome.44 
SUMMARY 
H L A antigens have been shown to be associated with several immunoinflam-
matory diseases. The mechanisms by which these antigens confer susceptibility to 
disease continue to be of major interest. Rapid progress has been made in the 
elucidation of the structure and function of class I and II M H C molecules, and 
several genes located within the HLA complex have been identified which are 
potentially involved in immunologic processes. 
Because of the HLA localization of the TNF-a and -/? genes and the biologic 
activities of the gene products, recent investigation has focused on a possible role of 
polymorphic TNF genes in the pathogenesis of HLA-associated diseases. Allelic 
variations have only been detected in the TNF-/? gene. No evidence has been found 
so far that a particular TNF-/? allele contributes signifkantly in the susceptibility to 
the diseases studied. 
Although it has been postulated that the TNF/?*2 allele contributes to suscepti-
bility to IDDM in HLA-DR3, 4 heterozygous individuals, a larger group of H L A -
typed patients and controls is needed to provide more conclusive evidence for this 
hypothesis. The increasing number of genes of unknown function encoded by the 
class III region leaves the possibility that the observed H L A associations in some 
diseases may be related to the presence of these genes.9 
In AS, the lack of association with the TNF-/? alleles furthermore supports the 
function of the HLA-B27 molecule in the disease and underlines the improbability 
that HLA-B27 is merely a marker for a closely linked susceptibility gene. 
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